These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 18198264)

  • 21. Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia.
    Cillóniz C; Ceccato A; de la Calle C; Gabarrús A; Garcia-Vidal C; Almela M; Soriano A; Martinez JA; Marco F; Vila J; Torres A
    PLoS One; 2017; 12(8):e0182436. PubMed ID: 28787020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.
    Ochoa-Gondar O; Vila-Corcoles A; Rodriguez-Blanco T; Gomez-Bertomeu F; Figuerola-Massana E; Raga-Luria X; Hospital-Guardiola I
    Clin Infect Dis; 2014 Apr; 58(7):909-17. PubMed ID: 24532544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy.
    Esposito S; Marchese A; Tozzi AE; Rossi GA; Da Dalt L; Bona G; Pelucchi C; Schito GC; Principi N;
    Pediatr Infect Dis J; 2012 Jul; 31(7):705-10. PubMed ID: 22426300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal pneumonia: differences according to blood culture results.
    Capelastegui A; Zalacain R; Bilbao A; Egurrola M; Iturriaga LA; Quintana JM; Gomez A; Esteban C; España PP
    BMC Pulm Med; 2014 Aug; 14():128. PubMed ID: 25096919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study.
    Mongardon N; Max A; Bouglé A; Pène F; Lemiale V; Charpentier J; Cariou A; Chiche JD; Bedos JP; Mira JP
    Crit Care; 2012 Aug; 16(4):R155. PubMed ID: 22894879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: importance of early adequate treatment.
    Garnacho-Montero J; García-Cabrera E; Diaz-Martín A; Lepe-Jiménez JA; Iraurgi-Arcarazo P; Jiménez-Alvarez R; Revuelto-Rey J; Aznar-Martín J
    Scand J Infect Dis; 2010 Mar; 42(3):185-92. PubMed ID: 20085422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia.
    Viasus D; Simonetti AF; Garcia-Vidal C; Niubó J; Dorca J; Carratalà J
    J Antimicrob Chemother; 2017 Feb; 72(2):547-553. PubMed ID: 27798219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?
    Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A
    Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia.
    Chokshi R; Restrepo MI; Weeratunge N; Frei CR; Anzueto A; Mortensen EM
    Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):447-51. PubMed ID: 17534677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.
    Fisman DN; Abrutyn E; Spaude KA; Kim A; Kirchner C; Daley J
    Clin Infect Dis; 2006 Apr; 42(8):1093-101. PubMed ID: 16575726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and microbiological aspects of acute community-acquired pneumonia due to Streptococcus pneumoniae.
    Cardinal-Fernández P; García Gabarrot G; Echeverria P; Zum G; Hurtado J; Rieppi G
    Rev Clin Esp (Barc); 2013 Mar; 213(2):88-96. PubMed ID: 23178082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality.
    Lujan M; Gallego M; Fontanals D; Mariscal D; Rello J
    Crit Care Med; 2004 Mar; 32(3):625-31. PubMed ID: 15090938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
    Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
    Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study.
    Ruiz LA; España PP; Gómez A; Bilbao A; Jaca C; Arámburu A; Capelastegui A; Restrepo MI; Zalacain R
    BMC Geriatr; 2017 Jun; 17(1):130. PubMed ID: 28633626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia.
    Georges H; Leroy O; Vandenbussche C; Guery B; Alfandari S; Tronchon L; Beaucaire G
    Intensive Care Med; 1999 Feb; 25(2):198-206. PubMed ID: 10193548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia.
    Malinis M; Myers J; Bordon J; Peyrani P; Kapoor R; Nakamatzu R; Lopardo G; Torres A; Feldman C; Allen M; Arnold F; Ramirez J
    Int J Infect Dis; 2010 Jan; 14(1):e22-7. PubMed ID: 19586789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of pre-hospital antibiotic use on community-acquired pneumonia.
    Simonetti AF; Viasus D; Garcia-Vidal C; Grillo S; Molero L; Dorca J; Carratalà J
    Clin Microbiol Infect; 2014 Sep; 20(9):O531-7. PubMed ID: 24707906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia.
    Ceccato A; Cilloniz C; Martin-Loeches I; Ranzani OT; Gabarrus A; Bueno L; Garcia-Vidal C; Ferrer M; Niederman MS; Torres A
    Chest; 2019 Apr; 155(4):795-804. PubMed ID: 30471269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment and outcomes for patients with bacteremic pneumococcal pneumonia.
    Berjohn CM; Fishman NO; Joffe MM; Edelstein PH; Metlay JP
    Medicine (Baltimore); 2008 May; 87(3):160-166. PubMed ID: 18520325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia.
    Wagenvoort GH; Sanders EA; de Melker HE; van der Ende A; Vlaminckx BJ; Knol MJ
    Vaccine; 2017 Mar; 35(14):1749-1757. PubMed ID: 28262334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.